EIF2AK2 and head and neck squamous cell carcinoma: <b>Conclusions:</b> In conclusion, these findings establish CAV2 as a critical regulator of HNSCC progression and Cetuximab sensitivity via post-translational modulation of the PACT-PKR axis.